Immunomodulatory effects of Yersinia pestis lipopolysaccharides on human macrophages

scientific article

Immunomodulatory effects of Yersinia pestis lipopolysaccharides on human macrophages is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/CVI.00336-09
P932PMC publication ID2812085
P698PubMed publication ID19889939

P2093author name stringHideyuki Takahashi
Haruo Watanabe
Shinji Saito
Motohiro Matsuura
Kazuyoshi Kawahara
P2860cites workFactors promoting acute and chronic diseases caused by yersiniaeQ36637747
Yersinia pestis type III secretion system-dependent inhibition of human polymorphonuclear leukocyte functionQ36804172
Synthetic lipid A with endotoxic and related biological activities comparable to those of a natural lipid A from an Escherichia coli re-mutantQ37051385
Effects of Psa and F1 on the adhesive and invasive interactions of Yersinia pestis with human respiratory tract epithelial cellsQ38484199
Activity of monosaccharide lipid A analogues in human monocytic cells as agonists or antagonists of bacterial lipopolysaccharide.Q39513148
Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosisQ39654111
Bacterial endotoxins: extraordinary lipids that activate eucaryotic signal transductionQ39936881
The pH 6 antigen is an antiphagocytic factor produced by Yersinia pestis independent of Yersinia outer proteins and capsule antigenQ40421231
Regulatory roles for CD14 and phosphatidylinositol in the signaling via toll-like receptor 4-MD-2.Q40903298
Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide responseQ41452286
Transmission of Yersinia pestis from an infectious biofilm in the flea vectorQ41461840
A rapid and simple microfluorometric phagocytosis assayQ41548176
Preparation and properties of a standardized lipopolysaccharide from salmonella abortus equi (Novo-Pyrexal)Q41658578
Lipid A-like molecules that antagonize the effects of endotoxins on human monocytesQ41660884
Structural requirements of lipid A responsible for the functions: a study with chemically synthesized lipid A and its analogues.Q54659769
Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products.Q55033421
Lipid A modification systems in gram-negative bacteriaQ24650951
Lipopolysaccharide endotoxinsQ24650970
Yersinia pestis--etiologic agent of plagueQ29619320
Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytesQ29619621
Modification of the structure and activity of lipid A in Yersinia pestis lipopolysaccharide by growth temperatureQ30836915
A triple mutant of Escherichia coli lacking secondary acyl chains on lipid A.Q31037616
Variation in lipid A structure in the pathogenic yersiniaeQ31067117
Structural analysis of Francisella tularensis lipopolysaccharide.Q31120898
Novel modification of lipid A of Francisella tularensisQ33206138
A comprehensive transposon mutant library of Francisella novicida, a bioweapon surrogateQ33268806
Yersinia pestis is viable with endotoxin composed of only lipid A.Q34048402
Role of Yersinia murine toxin in survival of Yersinia pestis in the midgut of the flea vectorQ34125533
Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesisQ34413354
Synthetic and natural Escherichia coli free lipid A express identical endotoxic activitiesQ34668829
Administration of a synthetic TLR4 agonist protects mice from pneumonic tularemia.Q34714290
Lack of in vitro and in vivo recognition of Francisella tularensis subspecies lipopolysaccharide by Toll-like receptorsQ35220354
Intraspecific diversity of Yersinia pestis.Q35745842
Intracellular survival mechanisms of Francisella tularensis, a stealth pathogen.Q36292504
Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor beta1 and beta2 chain expressionQ36367736
P433issue1
P921main subjectYersinia pestisQ153875
lipopolysaccharideQ421804
P304page(s)49-55
P577publication date2009-11-04
P1433published inClinical and Vaccine ImmunologyQ5133811
P1476titleImmunomodulatory effects of Yersinia pestis lipopolysaccharides on human macrophages
P478volume17

Reverse relations

cites work (P2860)
Q33771536An avirulent Burkholderia pseudomallei ∆purM strain with atypical type B LPS: expansion of the toolkit for biosafe studies of melioidosis
Q40293226Evasion of human innate immunity without antagonizing TLR4 by mutant Salmonella enterica serovar Typhimurium having penta-acylated lipid A.
Q38113080Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis.
Q38008395Host Defense and the Airway Epithelium: Frontline Responses That Protect against Bacterial Invasion and Pneumonia
Q61802943Inflammasomes, Autophagy, and Cell Death: The Trinity of Innate Host Defense against Intracellular Bacteria
Q38059703Lipopolysaccharide of Yersinia pestis, the Cause of Plague: Structure, Genetics, Biological Properties
Q28608164Lipopolysaccharides from Commensal and Opportunistic Bacteria: Characterization and Response of the Immune System of the Host Sponge Suberites domuncula
Q89878357Protection and Safety Evaluation of Live Constructions Derived from the Pgm- and pPCP1- Yersinia pestis Strain
Q54330361Pseudoalteromonas strains are potent immunomodulators owing to low-stimulatory LPS.
Q40995016Structural Modifications of Bacterial Lipopolysaccharide that Facilitate Gram-Negative Bacteria Evasion of Host Innate Immunity
Q36357954Structural diversity of Burkholderia pseudomallei lipopolysaccharides affects innate immune signaling
Q38647533The Characteristics and Function of Bacterial Lipopolysaccharides and Their Endotoxic Potential in Humans

Search more.